Patient–clinician discussions on lung cancer screening in the United States before and after 2021 guidelines
Patient-clinician discussions about lung cancer screening were lower in 2022 than 2020, despite revised guidelines that broadened eligibility. Research should explore strategies to increase awareness of lung cancer screening and prioritize discussions about screening among those who are uninsured and formerly smoked.
Authors
- Erin A. Hirsch (ORCID: https://orcid.org/0000-0002-3289-5422)
- Mark Reese (ORCID: https://orcid.org/0009-0008-7899-8874)
- Timothy J. Williamson (ORCID: https://orcid.org/0000-0002-3678-0657)
- Lisa Carter‐Harris (ORCID: https://orcid.org/0000-0002-6448-6033)
- Whitney M Brymwitt (ORCID: https://orcid.org/0009-0008-9395-567X)
Institutions
- Georgetown University Medical Center (US)
- Loyola Marymount University (US)
- Center for Discovery (US)
Publication Details
- Journal
- Translational Behavioral Medicine
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1093/tbm/ibaf039
- Citations
- 1
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52